Morgan Stanley maintains Altria Group at Equal-Weight, raises price target to $77 from $71

Morgan Stanley kept its Equal-Weight rating on Altria Group but increased its price target from $71 to $77, an 8.5% rise. The new target is close to the stock's recent close of $76.75.

Original reporting
Published Oct 30, 2026, 5:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 5:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley maintains Altria Group at Equal-Weight, raises price target to $77 from $71 — source image
Decision brief

The 30-second read

$MOBullishLow
01

Why it matters

The immediate trading relevance is sentiment and positioning around analyst expectations rather than a fresh fundamental driver.

02

Market read

Valuation sentiment for MO improves modestly due to the raised target, but the article lacks new operational or earnings information.

03

What to watch

Traders may discount the move if it is largely mechanical (target reset without new evidence) or if other banks issue conflicting downgrades/targets.

Relevance 4/10Novelty 4/10Timing: today, as the analyst target change is newly published

Background

The piece is an analyst update from Morgan Stanley on Altria Group’s rating and price target.

Company-level read

Ticker impact

$MOBullishMedium confidence
Context

Morgan Stanley maintained Altria Group at Equal-Weight and raised its price target to $77 from $71, implying a more constructive valuation view.

Expected impact

Likely mild upward bias as traders price in the higher target, though follow-through depends on broader tape and other analyst actions.

Evidence & confidence

The article contains only an analyst rating and price-target change, with no new company-specific operational, regulatory, or earnings datapoint.

Market effects

Could modestly support sentiment for tobacco value names if the target change is echoed by other analysts, but no sector-wide new data is provided.

No direct regional market linkage beyond US equity sentiment.

Limited, as the catalyst is a single US-listed analyst note.

Counterpoint

A higher price target may not translate into performance if underlying fundamentals or valuation multiples have not changed.

Key entities

  • Altria Group

    US tobacco company covered by Morgan Stanley in the note.

  • Morgan Stanley

    Analyst firm maintaining Equal-Weight and raising the price target.

Related articles

$MOHighAI 8/10

Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?

Altria (MO), Gilead (GILD), and ExxonMobil (XOM) reached 52-week highs after strong Q3 results. MO reported $1.52 EPS, raised guidance, and increased buybacks. GILD exceeded revenue/earnings expectations, boosting HIV growth outlook. XOM posted $4.23 EPS, raised dividend, and maintained buyback plan. All three stocks gained 1-3% on the day.

$MOHighAI 8/10

America’s Greatest Dividend Posts Strong Earnings

Altria (MO) reported Q3 revenue of $6.1B (+1% YoY) and EPS of $1.51 (+7% YoY), beating expectations. The company raised its full-year earnings guidance, citing strong performance. Shares rose 6% over two days and are up 33% YTD. CEO Sal Mancuso highlighted confidence in the full-year plan. Marlboro, with a 40% U.S. market share, drives most revenue. Other high-yield companies like UPS, Kraft Heinz, and General Mills face economic sensitivity and competition.

$MOMed

Goldman Sees More Upside in Altria After Strong Quarter

Goldman Sachs raised its price target for Altria (MO) to $83 from $77, citing better-than-expected Q3 earnings and revenue. Adjusted EPS was $1.52, beating estimates, and revenue reached $6.13B. Management increased its 2026 EPS growth outlook. Goldman expects continued benefits from tax drawbacks and a manufacturing agreement with Philip Morris. MO stock is up 40% year-to-date.

$MOHighAI 8/10

UBS raises Altria stock price target to $83 on strong quarter

UBS raised its price target on Altria Group (NYSE:MO) to $83, citing strong Q3 2026 revenue growth of 3.6% and raised EPS guidance. The stock trades near its 52-week high, up 43% over the past year. Altria's dividend yield is 5.79%, and it has raised dividends for 16 consecutive years. Recent earnings beat estimates, with EPS of $1.52 and revenue of $6.13 billion. Goldman Sachs and BofA Securities also raised their price targets.

$MOHighAI 8/10

What Just Happened To Altria Stock?

Altria (MO) shares rose 5.2% on October 29, 2026, after beating Q3 earnings estimates and raising its full-year guidance. The company reported adjusted earnings of $1.52 per share on $5.44 billion in revenue, exceeding forecasts. Management raised its 2026 earnings outlook to $5.66-$5.74 per share, up from prior guidance. The stock closed at $76.75, its highest in a year, with a 29.5% return over the past 12 months.